BioNTech SE (BNTX) has released its financial results for Q1 2024, detailing progress in its pipeline, including potentially registrational trials and clinical data presentations.
Read MoreBioNTech SE (BNTX) has released its financial results for Q1 2024, detailing progress in its pipeline, including potentially registrational trials and clinical data presentations.
Read More